Moleculin Biotech, (MBRX) shares skyrocketed early in the morning
Hasnain Khan
December 1, 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) surged 43.59% in the pre-market session after, a clinical-stage pharmaceutical corporation with a wide pipeline of drug candidates targeting highly